Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

Go back to Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
Danaher Corp. (NYSE: DHR) Delayed: 207.66 -3.37 (1.6%)
Previous Close $211.03    52 Week High $102.79 
Open $207.19    52 Week Low $75.71 
Day High $208.70    P/E 54.65 
Day Low $205.23    EPS $3.80 
Volume 2,898,177